Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Disease area: Respiratory infections

Abstract

The aim of work was to carry out an analysis of Yamal region citizens‘ relation to vaccination against a seasonal and pandemic influenza virus (PI).
Methods. The questionnaire of randomly selected adult people (N=75) was performed in city out-patient clinic in Oct 2009. The form included two questions devoted to people‘s relation to vaccination against seasonal and PI (after a vaccine will appear). Alternative answers were the following: "yes, I am inoculated", "I am not inoculated yet, but would like to do it", "I am not inoculated because find it dangerous and unhealthy", "I am not inoculated because find it ineffective", "other".
Results. 32% of people questioned turned out to be inoculated against seasonal flu, 29% of all would like to be inoculated, 9% are not inoculated because find it dangerous and unhealthy, 24% find it ineffective and 5% of people questioned are not inoculated due to the other reasons. If a vaccine against PI exists, 50% of people questioned would like to be inoculated; 17% would not like to be inoculated because find it dangerous and unhealthy, 20% of them find it ineffective and 12% would not like to be inoculated due to other reasons.
Conclusions. The results shown that 1/3 of all people questioned are inoculated against seasonal flu and almost as many ones would like to be inoculated. However, a big part of people questioned (24%) consider vaccination ineffective or dangerous to health (9%). Half of people wish to be inoculated in the future against PI. At the same time 37% of them consider it dangerous or ineffective. Informational and educational actions are required to be implemented more deeply in order to increase the level of people awareness in general in regard to this question.

Rating:

Share or cite this content

Citations should be made in the following way:
R. Bontsevich, T. Pertseva, R. Bontsevych (Labytnangi, Dnipropetrovs‘k, Russian Federation; Dnipropetrovs‘k, Ukraine). The relation of people to vaccination against an influenza virus. Eur Respir J 2010; 36: Suppl. 54, 2985

Member's Comments

No comment yet.

Related content which might interest you: Characteristics of patients diagnosed of influenza A virus (H1N1) infection in relation to service in charge Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology Year: 2010 Parents' attitude towards seasonal vaccination of children against an influenza virus Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 The influenza pandemic: 1918 compared to 2005 Source: Annual Congress 2005 - New developments in infectious disease Year: 2005 The spread of influenza viruses. State of the pandemic and prediction Source: Annual Congress 2009 - The influenza A (H1N1) pandemic Year: 2009 Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004 Influenza vaccination and its relation with LRTI Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 Early diagnosis and causal treatment of pneumonia associated with pandemic influenza A (H1N1) virus Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Pneumococcal and influenza vaccination Source: Respipedia Article Year: 2018 Searching for a pandemic influenza vaccine Source: International Congress 2014 – Virulent topics in respiratory infections Year: 2014 The severity of pandemic H1N1 influenza in Albania Source: Annual Congress 2010 - Pulmonary infections and sepsis Year: 2010 Assessing the potential pandemic risk of recent avian influenza viruses Source: Eur Respir J , 49 (3) 1602517; DOI: 10.1183/13993003.02517-2016 Year: 2017 Cytokine response in pediatric patients with pandemic H1N1 influenza virus infection and pneumonia: Comparison with pediatric pneumonia without H1N1 infection Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection Year: 2011 Impact of the COVID-19 pandemic on Influenza virus transmission Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 Influenza: vaccination and treatment Source: Eur Respir J 2001; 17: 1282-1293 Year: 2001 Avian influenza and SARS – how much of a threat is it to humans and what can be done to prevent this? Source: Annual Congress 2005 - Major viral threats to the lung Year: 2005 Socioeconomic correlates of SARS-CoV-2 and influenza H1N1 outbreaks Source: Eur Respir J, 56 (3) 2001400; 10.1183/13993003.01400-2020 Year: 2020 Monitoring the kinetics of a vaccine-induced T-cell response after H1N1 influenza vaccination Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Regional features of pneumonia caused by influenza during epidemics of influenza virus A (H1N1) in western Ukraine Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Assessment of the association between asthma and immune responses to measles and mumps vaccine viruses Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008